The founders of GreenWay DNA came together around a vision of providing personalized information that will help accelerate each individual’s path to wellness with the natural-healing powers of cannabinoids, the medicinal compounds produced by cannabis and hemp. We realized that bringing individuals the knowledge, based on their personal genetic information, of how their endocannabinoid system might be predisposed to function in response to phytocannabinoids (those cannabinoids that are produced by cannabis and hemp) would provide useful information for better understanding the potential efficacy of dose regimes of cannabinoids for the relief of conditions such as pain, anxiety, sleep disorders and other conditions.
A very personal story is at the heart of our mission. One of our founders’ mother, who is 78 years-old, suffers from Parkinson’s disease. The medication she was taking to control her tremors caused her to vomit for 30 minutes after medicating and was not an effective relief for her tremors; she still needed someone to feed her. After investigation into cannabis treatments for Parkinson’s, she was open to trying cannabis products, but she did not want to experience a “high” from the treatment. We spent 4 months and about $4,000 trying different rations of cannabinoids (CBD to THC ratios) until we discovered a CBD:THC ratio that addressed her tremors and did not make her “high”. Further, the appropriate CBD:THC ratio eliminated the side effects that she had previously experienced with her pharmaceutical prescription medication. Hearing about what was working for other people during this “trial and error” period but not working for this 78-year-old, it was clear that a path of wellness beyond randomly searching for the right dose and ratio of CBD and THC. GreenWay DNA is that better path to wellness!
There is a vast body of literature regarding the human endocannabinoid system, which is the innate system of receptors, enzymes and proteins that process cannabinoids as well as other compounds that regulate many aspects of human health and wellbeing. DNA encodes the genetic information to produce these receptors, enzymes and metabolic proteins, and no two people are identical with regard to the DNA sequences for these genes. This natural genetic variation affects how the endocannabinoid system functions differently in each person, and the variation can be readily determined by DNA sequence analysis to provide an overview of the genetic composition of the many genes involved in the perception and response to cannabinoids.
Phytocannabinoids derived from cannabis and hemp interact with our endocannabinoid system to influence how we feel and how our body and mind experience such basic conditions as the moderation of pain and anxiety. With the field of medicinal cannabinoid use rapidly expanding, there is now an opportunity to link the genetic information of a person’s own endocannabinoid system with the potential response to phytocannabinoids.
GreenWay DNA was created to bring our customers the knowledge of their own endocannabinoid system, based on their personal genetic information, and align this information with insights as to their potential response to particular dose regimes of phytocannabinoids for relief from, among other conditions, pain, anxiety and sleep disorders. According to a 2016 WebMD survey, 48% of medical cannabis patients take between 3 to 6 months or longer, and spend up to $3,000, to find the appropriate cannabinoid combination to address their condition. Information from your GreenWay DNA test is designed to help you efficiently identify the right dosage and ratio of CBD and THC to relieve you of the conditions affecting your individual well being.
GreenWay DNA is your first step to an informed path to wellness with medicinal cannabis products.